Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:43 AM
Ignite Modification Date:
2025-12-25 @ 1:43 AM
NCT ID:
NCT01724294
Eligibility Criteria:
Inclusion Criteria:
* Adult patients, \>18 years of age
* Patients with diagnosed diffuse large B-cell lymphoma in first-line treatment with R-CHOP
Exclusion Criteria:
* Prior chemotherapy treatment for diffuse large B-cell lymphoma
* Contra-indications or exclusion criteria according to the Summary of Product Characteristics for MabThera/Rituxan
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01724294
Study Brief:
Protocol Section:
NCT01724294